The health and safety of our employees, patients, customers and communities is our top priority. Read about our response to COVID-19

Inspire Medical Systems, Inc. to Report Third Quarter 2020 Financial Results on November 2, 2020

Download as PDF

MINNEAPOLIS – September 24, 2020 – Inspire Medical Systems, Inc. (NYSE: INSP)
(“Inspire”), a medical technology company focused on the development and
commercialization of innovative and minimally invasive solutions for patients with
obstructive sleep apnea, today announced that it will release financial results for the
third quarter 2020 after the close of trading on Monday, November 2. Inspire’s
management team will host a corresponding conference call beginning at 5:00 p.m.
Eastern Time to discuss the financial results and recent business developments.

Monday, November 2nd @ 5:00 p.m. Eastern Time:
Domestic: 877-407-0792
International: 201-689-8263
Conference ID: 13710653
Webcast: http://public.viavid.com/index.php?id=141564

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and
commercialization of innovative and minimally invasive solutions for patients with
obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-
approved neurostimulation technology that provides a safe and effective treatment for
moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
[email protected]
646-597-6989